EUVIMEDEUVIMED entdecken
Vergleichsstudie

Escalation to Biologics After Methotrexate Among US Veterans With Rheumatoid Arthritis Grouped by Rural Versus Urban Areas

Anisha Naik, Aaron Baraff, Katherine D Wysham iD, Jean W Liew, Bryant R England iD, Punyasha Roul, Michael George iD, Joshua F Baker, Jennifer L Barton iD, Una E Makris, Gail Kerr iD, Grant W Cannon iD und 2 weitere

Arthritis Care & Research · 2025

DOI: 10.1002/acr.25457 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Arthritis Care & Research, 2025. Verfasst von Anisha Naik und 13 weiteren Autor:innen. Beteiligte Einrichtung: VA Puget Sound Health Care System, Seattle, Washington. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Methotrexate, Antirheumatic Agents, Biological Products. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: VA Health Systems Research, NIA NIH HHS, Rheumatology Research Foundation Investigator award.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Racial and ethnic disparities in rheumatoid arthritis (RA) outcomes are well recognized. However, whether disparities in RA treatment selection and outcomes differ by urban versus rural residence, independent of race, have not been studied. Our objective was to evaluate whether biologic disease‐modifying antirheumatic drug (bDMARD) initiation after methotrexate administration differs by rural versus urban residence among veterans with RA.

Methods

In this retrospective cohort study using national US Veterans Affairs (VA) databases, we identified adult patients with RA based on the presence of diagnostic codes and DMARD administration. We included patients receiving an initial prescription of methotrexate (index date) between 2005 and 2014, with data through 2016 used for follow‐up. Urban–rural status was categorized using the Veteran Health Administration's Urban/Rural classification. Our primary outcome of interest was time to biologic initiation within two years of starting methotrexate. Multivariable Cox proportional hazards models were conducted adjusting for demographics, comorbidities, and rheumatoid factor or anti‐cyclic citrullinated peptide positivity.

Results

Among 17,395 veterans with RA (88% male, 42% with rural residence) fulfilling eligibility criteria, 3,259 (19%) initiated a biologic within the first two years of follow‐up. In multivariable models, residence in an urban area was associated with a statistically significant higher biologic administration compared to rural areas (adjusted hazard ratio 1.10 [95% confidence interval 1.02–1.18]).

Conclusion

Our study found only modest differences in the initiation of biologic therapies among rural‐ versus urban‐residing veterans with RA in the VA health care system. These findings suggest that disparities are not easily explained by rurality within the VA health care system.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arthritis, RheumatoidMethotrexateAntirheumatic AgentsBiological ProductsHumansMaleFemaleRetrospective StudiesMiddle AgedUnited StatesAgedTreatment OutcomeHealthcare DisparitiesDatabases, FactualUnited States Department of Veterans AffairsVeteransTime Factors

Substanzen

MethotrexateAntirheumatic AgentsBiological Products

Autor:innen und Institutionen

  • VA Puget Sound Health Care System, Seattle, Washington.
  • VA Puget Sound Health Care System and University of Washington, Seattle.
  • Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts.
  • VA Nebraska-Western Iowa Health Care System and University of Nebraska Medical Center, Omaha.
  • University of Pennsylvania and VA Medical Center, Philadelphia.
  • VA Portland Health Care System and Oregon Health and Science University, Portland.

ORCID-Profile: Katherine D Wysham, Bryant R England, Michael George, Jennifer L Barton, Gail Kerr, Grant W Cannon, Ted R Mikuls, Namrata Singh

Förderung

  • VA Health Systems Research
  • NIA NIH HHS
  • Rheumatology Research Foundation Investigator award
  • NIAMS NIH HHS
  • VA Clinical Science Research and Development
  • VA Biomedical Laboratory Research and Development
  • Rheumatology Research Foundation
  • CSRD VA

Zitieren

APA

Naik, A., Baraff, A., Wysham, K. D., Liew, J. W., England, B. R., Roul, P., George, M., Baker, J. F., Barton, J. L., Makris, U. E., Kerr, G., Cannon, G. W., Mikuls, T. R., & Singh, N. (2025). Escalation to Biologics After Methotrexate Among US Veterans With Rheumatoid Arthritis Grouped by Rural Versus Urban Areas. Arthritis Care & Research. https://doi.org/10.1002/acr.25457

Vancouver

Naik A, Baraff A, Wysham KD, Liew JW, England BR, Roul P, et al. Escalation to Biologics After Methotrexate Among US Veterans With Rheumatoid Arthritis Grouped by Rural Versus Urban Areas. Arthritis Care & Research. 2025. doi:10.1002/acr.25457

BibTeX
@article{Naik2025,
  author = {Naik, Anisha and Baraff, Aaron and Wysham, Katherine D and Liew, Jean W and England, Bryant R and Roul, Punyasha and George, Michael and Baker, Joshua F and Barton, Jennifer L and Makris, Una E and Kerr, Gail and Cannon, Grant W and Mikuls, Ted R and Singh, Namrata},
  title = {Escalation to Biologics After Methotrexate Among US Veterans With Rheumatoid Arthritis Grouped by Rural Versus Urban Areas},
  journal = {Arthritis Care & Research},
  year = {2025},
  doi = {10.1002/acr.25457}
}
Kostenlos starten →